These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22670890)

  • 41. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
    Abe Y
    Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
    Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE
    J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease : an observational study in Belgium.
    Verstreken F; Degreef I; Decramer A; Libberecht K; Vanhove W; Datco A; Vanhaecke J; Clermont D; Duerinckx J
    Acta Orthop Belg; 2016 Aug; 82(2):397-404. PubMed ID: 27682305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of Collagenase Treatment for Dupuytren Disease.
    Badalamente MA; Hurst LC
    Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique.
    Verheyden JR
    J Hand Surg Eur Vol; 2015 Feb; 40(2):133-40. PubMed ID: 24698852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ▾Xiapex for Dupuytren's contracture.
    Drug Ther Bull; 2011 Dec; 49(12):138-41. PubMed ID: 22170410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2 year follow-up of 47 patients.
    McFarlane J; Syed AM; Sibly TF
    J Hand Surg Eur Vol; 2016 Jul; 41(6):664-5. PubMed ID: 26269508
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture.
    Badalamente MA; Hurst LC
    J Hand Surg Am; 2007; 32(6):767-74. PubMed ID: 17606053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].
    Keller M; Arora R; Schmiedle G; Kastenberger T
    Orthopade; 2017 Apr; 46(4):321-327. PubMed ID: 28138723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
    Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
    BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
    Sanjuan-Cervero R; Carrera-Hueso FJ; Oliver-Mengual S; Ramon-Barrios MA; Peimer CA; Fikri-Benbrahim N
    Orthop Nurs; 2018; 37(2):144-153. PubMed ID: 29570549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
    Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
    Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of efficacy and safety of treatment with collagenase Clostridium histolyticum among subgroups of patients with Dupuytren contracture.
    Raven RB; Kushner H; Nguyen D; Naam N; Curtin C
    Ann Plast Surg; 2014 Sep; 73(3):286-90. PubMed ID: 23511746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.
    Sanjuan-Cervero R
    Ir J Med Sci; 2020 May; 189(2):529-534. PubMed ID: 31713028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures.
    Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC
    J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dupuytren's disease treatment].
    Kornø MR; Søe N; Dahlin LB
    Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can collagenase effectiveness in Dupuytren's contracture be improved by using ultrasound-guided Injection? A comparative study.
    Aguilella L; Pérez-Giner R; Higueras-Guerrero V; Belloch-Ramos E; Cuenca-Torres M; Juan EL
    J Plast Surg Hand Surg; 2022 Feb; 56(1):23-29. PubMed ID: 33840343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New treatment options for Dupuytren's surgery: collagenase and percutaneous aponeurotomy.
    Srinivasan RC; Shah AS; Jebson PJ
    J Hand Surg Am; 2010 Aug; 35(8):1362-4. PubMed ID: 20434276
    [No Abstract]   [Full Text] [Related]  

  • 59. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Zhang P; Qin L
    N Engl J Med; 2009 Dec; 361(26):2578-9; author reply 2579-80. PubMed ID: 20032329
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
    Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
    BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.